Corcept Therapeutics $80.93 (-5.02, 5.84%)

NASDAQ
98% success, from Analysis 77* of this Model (*Public)
Summary
SHORTSELL: Best moves 25 which gains 1727.17, return on capital invested 20.65%
Date Name (*Public) Description Symbol Type Size Action
Date Value Error Logarithmic Error
Details Best Trend by Hindsight Forecast Profit or Loss
Date (*Public) Symbol Strategy Data Origin Slope Sigma Cor % Moves Sigma Moves Gain % Periods Action
Date UTC Location Action Description Object Severity User Action